Over 30% Of Covaxin Takers Report Adverse Effect, Claims BHU Study; Menstrual Abnormalities Seen In Women
The study, which was published in the journal Springer Nature, claimed around 50 per cent reportedly complained of infections during the follow-up period, which was dominated by viral upper respiratory tract infections.
May 17, 2024, 10:10 AM IST
Govt clears Corbevax as Covid-19 booster dose for adults vaccinated with Covaxin, Covishield
This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.
Aug 10, 2022, 12:53 PM IST
CORBEVAX becomes first vaccine in India to get DCGI approval for COVID-19 booster dose
CORBEVAX has become the first vaccine in India to get DCGI approval for COVID-19 booster dose.
Jun 04, 2022, 17:28 PM IST
Germany clears Bharat Biotech’s Covaxin, no vaccination proof required for fliers from June 1
“Germany has approved Covaxin COVID19 vaccine. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions,” Bharat Biotech said on Twitter.
May 26, 2022, 13:59 PM IST
Sputnik booster dose approved in India, more than 6.5 lakh people eligible: Report
More than 6.5 lakh people who have received Sputnik COVID vaccine will soon be eligible to take the booster dose.
May 07, 2022, 14:28 PM IST
Bharat Biotech seeks approval for Covaxin booster trials for 2-18 age group
Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population.
May 05, 2022, 19:37 PM IST
Vaccine Breaking : DCGI grants emergency approval to Covaxin and Corbevax for children below 12
In India, now even 5-year-old children can be given vaccinated against coronavirus. Corbevax vaccine of Biological E Company has been approved for those between 5 to 12 years of age while Covaxin will be given to children between 6 to 12 years of age. These vaccines are administered in two doses each of which is given at an interval of 28 to 40 days
Apr 26, 2022, 15:30 PM IST
DCGI gives emergency use nod to Covaxin for kids aged 6-12 amid fourth wave scare
The Drugs Controller General of India (DCGI) has given a restricted emergency use authorisation to Bharat Biotech's Covaxin for children aged 6-12 years, ANI news agency reported on Tuesday (April 26, 2022).
Apr 26, 2022, 13:06 PM IST
Japan recognizes India's Covaxin to facilitate travel between both countries
Japan has recognised the Covid-19 vaccine COVAXIN by Bharat Biotech, for 1st and 2nd dose with effect from 10 April further ease the travel from India to Japan.
Apr 08, 2022, 16:56 PM IST
WHO’s supply suspension of Covaxin to impact travel by people? Details here
In terms of their travel, the vaccine continues to be recognized under the emergency use listing of WHO and various countries have already accepted it, said MEA spokesperson Arindam Bagchi.
Apr 08, 2022, 07:17 AM IST
WHO's suspension of Bharat Biotech's Covaxin supply is only for UN agencies: Sources
The Hyderabad based Bharat Biotech`s anti-Covid Vaccine, Covaxin has been suspended by WHO under the Covax facility, announced the UN health body on Saturday, attributing it to deficiencies in manufacturing practices.
Apr 04, 2022, 16:09 PM IST
No impact on efficacy and safety of Covaxin, clarifies Bharat Biotech after WHO suspension
"The risk assessment to date does not indicate a change in the risk-benefit ratio. The data available to WHO, indicate the vaccine is effective and no safety concern exists," said Bharat Biotech.
Apr 04, 2022, 13:30 PM IST
WHO suspends UN supply of Bharat Biotech's Covaxin vaccine for Covid-19
The WHO said the Bharat Biotech vaccine is effective and no safety concerns exist, but the suspension of production for export will result in the interruption of Covaxin supply.
Apr 03, 2022, 12:26 PM IST
Covaxin to be evaluated as Covid-19 vaccine candidate in US: Bharat Biotech
US Food and Drug Administration (FDA) has lifted its clinical hold on the Ocugen, Inc Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States.
Feb 19, 2022, 21:21 PM IST
DCGI grants regular market approval to Covishield, Covaxin, details here
These Covid-19 vaccines will not be available in medical stores.
Jan 27, 2022, 16:02 PM IST
Covishield, Covaxin likely to be capped at Rs 275 after regular market approval
The price is likely to be capped at Rs 275 per dose along with an additional service charge of Rs 150.
Jan 26, 2022, 16:13 PM IST
Covishield, Covaxin regular market approval recommended by govt panel
An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said.
Jan 19, 2022, 22:33 PM IST
No Covid vaccine shortage in Maharashtra, Centre refutes media reports
The Centre said media reports are "not factually correct and do not reflect the correct picture of the available stock of balance and unutilised Covid vaccine doses with Maharashtra".
Jan 14, 2022, 16:36 PM IST
Covaxin booster shot neutralises Omicron, says Bharat Biotech
The study was conducted at the Emory Vaccine Center in Atlanta based on blood serum collected from 13 individuals, 28 days after their booster shot, the Bharat Biotech said.
Jan 12, 2022, 18:47 PM IST
Covaxin booster dose trial shows 'long-term safety': Bharat Biotech
Based on emerging data, Bharat Biotech believes that a third dose may be beneficial to maintain the highest levels of protection.
Jan 08, 2022, 21:45 PM IST
